| Tumor
Angiogenesis and Vascularity Hall C |
| Th 1323. How Dormant are Dormant Tumors? Oscillations in the Angiogenic Switch, A. Gilead, A. Uziel, Z. Agur and M. Neeman, The Weizmann Institute of Science, Rehovot, Israel and Tel Aviv University, Tel Aviv, Israel. |
| M 1324. Effect of ZD4190, a VEGF Receptor Tyrosine Kinase Inhibitor, on Endothelial Permeability in Human Tumour Xenografts, D. Checkley, B. Curry, M. Dukes, J. Kendrew, J.J. Tessier, J.C. Waterton and S.R. Wedge, Zeneca Pharmaceuticals, Macclesfield, Cheshire, UK. |
| T 1325. Dynamic Flow Studies in Mammary Carcinomas after Treatment with the PKC Inhibitor Bryostatin-1, J.P. Dyke, C.M. Matei, G. Schwartz, D.J. Ballon, J.A. Koutcher and K.L. Zakian, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. |
| W 1326. Protamine as an Anti-angiogenesis Agent for Cancer Therapy: Blood Coagulation of Tumor Feeding Vessels Measured by MRI, M-Y. Su, M.K. Samoszuk, Y. Song and O. Nalcioglu, University of California, Irvine, CA, USA. |
| Th 1327. Dynamic Contrast-Enhanced MR Imaging of Uterine Cervical Cancer: Pharmacokinetic Analysis with Histologic Correlation and its Prognostic Significance after Radiation Therapy, Y. Yamashita, T. Baba, Y. Baba, R. Nishimura, M. Takahashi and H. Okamura, Kumamoto University School of Medicine, Kumamoto, Japan. |
| M 1328. Uterine Cervical Carcinoma: Comparison of Standard and Pharmacokinetic Analysis of Time-Intensity Curves for Assessment of Tumor Angiogenesis and Patient Survival, H. Hawighorst, P.G. Knapstein, M. Essig, S. Schönberg, P. Vaupel, G. Brix and G. van Kaick, German Cancer Research Center, Heidelberg, Germany and University of Mainz, Germany. |
| T 1329. Radiosurgery of Malignant Glioma: Prediction of Tumor Response after Irradiation by Pharmacokinetic MR Imaging, H. Hawighorst, J. Debus, K. Eichhorn, H. Schlemmer, M.V. Knopp and G. van Kaick, German Cancer Research Center and University of Heidelberg, Heidelberg, Germany. |
| W 1330. Necrotic Fraction Estimation of Osteogenic Sarcomas Undergoing Induction Chemotherapy using FMPSPGR Dynamic Perfusion Imaging, J.P. Dyke, D.M. Panicek, P.A. Meyers, J.H. Healey, A.G. Huvos, L.H. Schwartz, J.A. Koutcher and D. Ballon, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. |
| Th 1331. Investigation of the Enhanced Delivery of Small and Macromolecular Agents into Tumors under Hypertension Condition Induced by a Vasoconstricto, M-Y. Su and O. Nalcioglu, University of California, Irvine, CA, USA. |
| M 1332. Drug Delivery to Tumors: Potential of MR for Measurement and Prediction, D. Artemov and Z.M. Bhujwalla, The Johns Hopkins University School of Medicine, Baltimore, MD, USA. |
| T 1333. Evaluating the Anti-Tumour Activity of New Vascular Damaging Agents using Magnetic Resonance Spectroscopy, T. Breidahl, F.U. Nielsen, R.J. Maxwell, H.S. Joergensen and M.R. Horsman, Aarhus University Hospital, Aarhus, Denmark and Mount Vernon Hospital, Northwood, UK. |
| W 1334. Evaluation of Tumor Perfusion by 2H-MRI of MCF7 Breast Cancer, L. Bogin, R. Edgar, R. Margalit, J. Mispelter and H. Degani, Weizmann Institute of Science, Rehovot, Israel and Centre Universitaire, Orsay, France. |
| Th 1335. Tumor Oxygen Tension Mapping Using the Vascular Volume Fraction as Measured by the Dynamic Contrast Enhanced MRI, Z. Wang, M-Y. Su and O. Nalcioglu, University of California, Irvine, CA, USA. |
| M 1336. Tumor Vascularity and Reactivity: Human Glioma in a Nude Rat Model, S.D. Packard, J.B. Mandeville, K. Ikeda, E.A. Chiocca, B.R. Rosen and J.J.A. Marota, Massachusetts General Hospital, Charlestown, MA, USA. |
| T 1337. A Strategy to Quantitatively Estimate Tumor Blood Volume with Gd-DTPA, M. Karlsson and B. Nordell, Karolinska Institute, Stockholm, Sweden. |
| W 1338. Quantification of Fractional Blood Volume Under Effects of Inflow and Water Exchange, Y.R. Kim, R. Cox and K.M. Donahue, Medical College of Wisconsin, Milwaukee, WI, USA. |
| Th 1339. Quantitative Evaluation of Glioma Vascularization, Permeability and Interstitial/Cell Volume by MRI, L. Lüdemann and C. Zimmer, Charité, Berlin, Germany. |
| M 1340. Quantitative Measurement of Vascular Permeability of Gliomas by Double Echo Dynamic MRI: A Preliminary Study, H. Uematsu, M. Maeda, N. Sadato, T. Matsuda, Y. Koshimoto, H. Yamada, H. Kimura, Y. Kawamura, N. Hayashi, Y. Yonekura and Y. Ishii, Fukui Medical University, Fukui, Japan and GE-Yokogawa Medical Systems, Tokyo, Japan. |
| T 1341. Improved Imaging of Tumor Vasculature: MR Spectroscopic Imaging of the Water Resonance Combined with a Superparamagnetic Contrast Agent, G.S. Karczmar, J.N. River, K. Tarlo, K. Kellar, X. Fan, H. Al-Hallaq, M. Zamora and C. Rinker-Schaeffer, University of Chicago, Chicago, IL, USA and Nycomed Amersham Imaging, Wayne, PA, USA. |